Adhésion à la bithérapie pégylée au cours de l’hépatite chronique C
Authors:
- C. Wartelle-BladouCWC. Wartelle-Bladou
- E. RosenthalERE. Rosenthal
- V. RatziuVRV. Ratziu
- V. De LédinghenVLV. De Lédinghen
- J.-P. LangJLJ.-P. Lang
- T. PoynardTPT. Poynard
- 1 March 2008
- journal article
- review article
- Published by Elsevier in Gastroentérologie Clinique Et Biologique
- Vol. 32 (3) , S96-S108
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Malades atteints d’hépatite chronique C non répondeurs : définitions de la non-réponse et stratégies thérapeutiquesGastroentérologie Clinique Et Biologique, 2007
- Impact of Ribavirin Dose Reductions in Hepatitis C Virus Genotype 1 Patients Completing Peginterferon Alfa-2a/Ribavirin TreatmentClinical Gastroenterology and Hepatology, 2007
- Treating chronic hepatitis C with pegylated interferon alfa‐2a (40 KD) and ribavirin in clinical practiceAlimentary Pharmacology & Therapeutics, 2006
- Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremiaJournal of Hepatology, 2006
- Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patientsGastroenterology, 2005
- Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis CAnnals of Internal Medicine, 2004
- Early Virologic Response to Treatment With Peginterferon Alfa–2B Plus Ribavirin in Patients With Chronic Hepatitis CHepatology, 2003
- Adherence to combination therapy enhances sustained response in genotype-1–infected patients with chronic hepatitis CGastroenterology, 2002
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialThe Lancet, 2001